5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Sudeep Pharma Ltd.

•
sudeepgroup.comBSE: 544619NSE: SUDEEPPHRM
Market Cap₹ 14,412 Cr.
Current Price
High / Low₹ 1,378 / 524
Stock P/E78.9
Book Value₹ 82
Price to Book7.57
Dividend Yield0.12 %
ROCE28.5 %
ROE25.4 %
Face Value₹ 1

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Pharmaceutical, Food & Nutrition: 56.5% • Speciality Ingredients: 43.5%

AI Sector View

AI GENERATED

Chemicals

Hold

The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.

Confidence
55%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 39.2% CAGR over last 5 years
  • Company has a healthy return on capital (ROCE) of 37.7%
  • Company has a good return on equity (ROE) track record: 3 Years ROE 34.7%
  • Company has consistently been profitable over the last 5 years
  • Company has delivered good sales growth of 24.5% CAGR over last 5 years
  • Operating margins have improved to 34.1% from 23.3%

CONS

  • Promoter holding has decreased over last 2 years: -23.8pp
  • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.41x)
  • Equity base is being diluted - shares outstanding up 701.6%
  • Working capital days have increased from 174 to 235 days
  • Stock is trading at 7.6x its book value

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

ChemicalsHealthcarePharmaceuticals & Drugs
Part ofNIFTY MICROCAP250NIFTY TOTAL MKT
S.No.Name
1.SUNPHARMA1868.5037.06448315.740.862901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9482.7586.06251737.220.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4931.9086.01187593.620.77566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1129.0024.95112618.180.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1368.0032.79110515.040.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1933.2595.54104455.860.10362.07123.942026.3129.1018.2031.50
7.AUROPHARMA1690.0026.1997238.860.241032.0325.229150.3517.4412.7620.54
8.LUPIN2092.0017.3095660.020.861416.9816.018276.8934.2828.8629.59
9.DRREDDY1143.2029.6195420.610.70435.60-69.108099.80-5.2113.7510.63
10.MANKIND2266.0045.8293596.020.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2439.5538.2968850.120.10482.83927.884018.4831.3520.3520.03
12.SUDEEPPHRM1276.0078.9114412.240.12405.871197.991582.701166.9928.5034.70
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
149116158125163172182158
85769986107112120109
Operating Profit6339593955606349
OPM %42.65%34.01%37.31%31.15%34.10%34.80%34.33%30.86%
224510765
Interest11222122
Depreciation33334444
Profit before Tax6238584460626354
Tax %21.01%23.77%23.63%29.05%21.43%22.79%22.59%25.24%
Net Profit0003147484941
4.492.654.072.844.204.294.383.59

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
123215343429459502642676
98171276339277311419449
Operating Profit25446790182191223227
OPM %20.64%20.49%19.67%21.03%39.73%38.05%34.69%33.58%
33710692929
Interest11265798
Depreciation34589111516
Profit before Tax25436986175183228238
Tax %26.68%22.50%26.87%27.52%23.81%24.13%23.58%22.96%
Net Profit18335062133139174184
EPS128.02236.61356.015.74945.2614.2715.31—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%9.80%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
24%
3 Years:
14%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
39%
3 Years:
41%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
—

RETURN ON EQUITY

10 Years:
—
5 Years:
34%
3 Years:
35%
Last Year:
25%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Jul 23

₹ 1.50

Rs.1.5000 per share(150%)Final Dividend

2026

Jul 10

₹ 1.50

Rs.1.5000 per share(150%)Final Dividend

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
111111011
Minority Interest00000015
80113162222355481872
2031848368127167
Trade Payables9182738516068
21507075393940
Total Liabilities1312133444205147171,174
6068137158180189337
Capital Work in Progress8248264588178
61903000
917377167129216
0000145185228
Cash & Bank41221101452115
44731411516373101
Total Assets1312133444205147171,174

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
16461571664970
Cash from Investing-22-40-38-50-49-79-331
Cash from Financing121351-10-1353247
-0810-11423-14

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Nov 2025Dec 2025Mar 2026Jun 2026
100.00100.00100.00100.0044.6576.1576.1576.1576.15
0.000.000.000.000.001.541.671.551.81
0.000.000.000.000.0014.1017.5918.1115.65
Government0.000.000.000.000.000.000.000.000.00
0.000.000.000.0055.358.204.584.186.39

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-11
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-11 - Sudeep Pharma Limited has informed the Exchange about Transcript

2026-08-06
Updates

2026-08-06 - Sudeep Pharma Limited has informed the Exchange regarding 'General Update'.

2026-08-05
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-05 - Sudeep Pharma Limited has informed the Exchange about Link of Recording

2026-08-05
Shareholders meeting

2026-08-05 - Sudeep Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 04, 2026. Further, the company has informed the Exchange regarding voting results.

2026-08-05
Copy of Newspaper Publication

2026-08-05 - Sudeep Pharma Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-04
Investor Presentation

2026-08-04 - Sudeep Pharma Limited has informed the Exchange about Investor Presentation

2026-08-04
Investor Presentation

2026-08-04 - Sudeep Pharma Limited has informed the Exchange about Investor Presentation

2026-08-04
Outcome of Board Meeting

2026-08-04 - Sudeep Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-08-04
Shareholders meeting

2026-08-04 - Sudeep Pharma Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 04, 2026

News

Recent coverage and analyst commentary for SUDEEPPHRM

Loading news…

🤖

AI Stock Analyst

Sudeep Pharma Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme


5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login